Rational Design of Novel pyrazolo[4,3-c]quinoline Derivatives as Potent, Selective, and Orally Bioavailable ATM

Tao Yang1,2, Tao Guo3, Yongting Yuan3

  • 1National Chengdu Center for Safety Evaluation of Drugs, West China Hospital, Sichuan University, Chengdu 610041, China.

PubMed

Insights

A new compound, A36, effectively inhibits ATM kinase, enhancing colorectal cancer cell sensitivity to chemotherapy and radiation. This promising drug candidate shows significant tumor growth inhibition when combined with irinotecan.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • ATM is crucial for DNA double-strand break repair.
  • ATM inhibition sensitizes colorectal cancer cells to chemotherapy and radiotherapy.
  • ATM is a potential therapeutic target in colorectal cancer.

Purpose of the Study:

  • To develop novel pyrazolo[4,3-c]quinoline derivatives as ATM inhibitors.
  • To optimize compounds for ATM selectivity and metabolic stability.
  • To evaluate the efficacy of the optimized compound A36 in preclinical colorectal cancer models.

Main Methods:

  • Rational structural design and synthesis of pyrazolo[4,3-c]quinoline derivatives.
  • In vitro assays for ATM and DNA-PK inhibition.
  • In vitro metabolic stability and pharmacokinetic studies.
  • Colorectal cancer cell line studies for chemosensitization and radiosensitization.
  • In vivo efficacy studies using colorectal cancer xenograft models in combination with irinotecan.

Main Results:

  • A series of pyrazolo[4,3-c]quinoline derivatives with ATM inhibitory activity were developed.
  • The optimized compound A36 exhibited potent subnanomolar ATM inhibition and excellent kinase selectivity.
  • A36 demonstrated strong cellular sensitization to radiation and chemotherapeutic agents.
  • A36 showed favorable pharmacokinetic properties (F% = 80.5%).
  • Combination of A36 with irinotecan resulted in enhanced antitumor efficacy and synergistic effects in xenograft models (TGI up to 92.6%).

Conclusions:

  • Compound A36 is a potent and selective ATM inhibitor with favorable drug-like properties.
  • A36 effectively sensitizes colorectal cancer cells to standard therapies.
  • A36 shows significant promise as a therapeutic agent for combination chemotherapy in colorectal cancer treatment.

Related Concept Videos

Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
369
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
162
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
591
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
251
Rationalizing Substitutions01:29

Rationalizing Substitutions

Integrals involving non-rational functions are often difficult to evaluate using standard techniques, especially when radicals appear in the integrand. Rationalizing substitution provides a systematic method for simplifying such integrals by converting them into rational forms that are easier to handle.Consider a rod whose linear mass density depends on a constant linear density, a characteristic length, and the distance from the left end of the rod. Determining the total mass requires...
62
Rational Expressions01:28

Rational Expressions

Rational expressions are algebraic fractions in which both the numerator and the denominator are polynomials. These expressions follow the arithmetic rules of numerical fractions but require extra care due to the presence of variables. A fundamental part of working with rational expressions is identifying values that make the expression undefined, typically those that result in division by zero or undefined radicals.Determining the DomainThe domain of a rational expression includes all real...
412